12:00 AM
Nov 12, 2012
 |  BC Week In Review  |  Company News  |  Deals

PsychoGenics, Dainippon Sumitomo deal

PsychoGenics received a milestone payment from Dainippon's Sunovion Pharmaceuticals Inc. subsidiary under an August 2007 deal to develop treatments for CNS disorders. The...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >